Firstly, our results showed that Naringenin did not changes the percentage of CD3+ cells between groups, although Naringenin treatment increased the percentage of CD4+ cells, similar to cyclophosphamide, the conventional treatment against SLE (Fig 4A). Here, CD4 is linked to systemic lupus erythematosus.